Efficacy of Mirabegron Compared with Tolterodine, Placebo, and Different Doses of Mirabegron on OAB Patient Evaluated in 4 Weeks Period: A Meta-Analysis
Christian Nurtanto Putra, Kevin Ivandi, Kadek Adit Wiryadana, Pande Made Wisnu Tirtayasa & Gede Wirya Kusuma Duarsa · Asian Journal of Research and Reports in Urology · 2021
Introduction: Mirabegron is one of the therapeutic options in overactive bladder where its efficacy and safety are better than antimuscarinics in several existing studies. Tolerability, treatment duration, and cost are often the deciding points for patient adherence and complianc...
Open access
Research Article